Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
Titel:
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
Auteur:
Hansen, A.R. Massard, C. Ott, P.A. Haas, N.B. Lopez, J.S. Ejadi, S. Wallmark, J.M. Keam, B. Delord, J.-P. Aggarwal, R. Gould, M. Yang, P. Keefe, S.M. Piha-Paul, S.A.